" /> Obinutuzumab Followed by Gemcitabine/Glofitamab/Oxaliplatin Regimen - CISMeF





Preferred Label : Obinutuzumab Followed by Gemcitabine/Glofitamab/Oxaliplatin Regimen;

NCIt synonyms : Obinutuzumab Followed by GemOx/Glofitamab Regimen; GemOx/Obinutuzumab/Glofitamab; GemOx-Glofitamab-Obinutuzumab; GemOx/Glofitamab/Obinutuzumab Regimen; Obinutuzumab Followed by GemOx/Glofitamab-gxbm Regimen; Gemcitabine/Glofitamab/Obinutuzumab/Oxaliplatin Regimen; Gazyva Followed by Gemcitabine/Oxaliplatin Plus Columvi; Gazyva Followed by GemOx-Columvi; Gazyva Followed by GemOx Plus Columvi; GemOx/Glofitamab-gxbm/Obinutuzumab;

NCIt definition : A regimen consisting of obinutuzumab followed by gemcitabine, glofitamab and oxaliplatin that can be used for the treatment of diffuse large B-cell lymphoma (DLBCL).;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
19/08/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.